GSA Capital Partners LLP Has $1.27 Million Stake in LivaNova PLC (NASDAQ:LIVN)

GSA Capital Partners LLP lifted its position in LivaNova PLC (NASDAQ:LIVN - Free Report) by 313.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,298 shares of the company's stock after purchasing an additional 24,483 shares during the period. GSA Capital Partners LLP owned about 0.06% of LivaNova worth $1,269,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. Freestone Grove Partners LP acquired a new position in LivaNova in the fourth quarter valued at about $23,102,000. The Manufacturers Life Insurance Company increased its stake in shares of LivaNova by 163.6% during the fourth quarter. The Manufacturers Life Insurance Company now owns 546,387 shares of the company's stock worth $25,303,000 after acquiring an additional 339,139 shares during the period. AQR Capital Management LLC increased its holdings in shares of LivaNova by 79.3% in the 4th quarter. AQR Capital Management LLC now owns 742,180 shares of the company's stock valued at $34,214,000 after purchasing an additional 328,313 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of LivaNova by 12.7% during the 4th quarter. Vanguard Group Inc. now owns 2,349,887 shares of the company's stock worth $108,823,000 after buying an additional 265,291 shares during the last quarter. Finally, Capital Research Global Investors boosted its position in LivaNova by 19.1% during the fourth quarter. Capital Research Global Investors now owns 1,612,818 shares of the company's stock worth $74,690,000 after acquiring an additional 258,730 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

LivaNova Stock Up 2.9%

Shares of NASDAQ:LIVN traded up $1.18 during midday trading on Monday, hitting $42.31. The stock had a trading volume of 398,146 shares, compared to its average volume of 693,230. The company has a market cap of $2.31 billion, a P/E ratio of -10.41 and a beta of 0.92. LivaNova PLC has a 12 month low of $32.48 and a 12 month high of $57.35. The business's 50-day simple moving average is $44.64 and its 200-day simple moving average is $42.83. The company has a quick ratio of 1.37, a current ratio of 1.58 and a debt-to-equity ratio of 0.53.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on LIVN. Wolfe Research raised shares of LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 target price on the stock in a research report on Tuesday, May 20th. Needham & Company LLC reiterated a "buy" rating and issued a $64.00 price target on shares of LivaNova in a research report on Tuesday, May 13th. Robert W. Baird increased their target price on shares of LivaNova from $55.00 to $61.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. Barclays reduced their price objective on shares of LivaNova from $56.00 to $55.00 and set an "equal weight" rating for the company in a research note on Thursday, May 8th. Finally, Wall Street Zen cut LivaNova from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 8th. One research analyst has rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $59.29.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.